Liver enzymes and lipid profile: Markers for disease management in HIV/AIDS patients on ART and ART- naive.

Karanpreet Bhutani; KMDS Panag

Volume : VII, Issue : VII, July - 2018

Liver enzymes and lipid profile: Markers for disease management in HIV/AIDS patients on ART and ART- naive.

Karanpreet Bhutani, Kmds Panag

Abstract :

Introduction

AIDS is a fatal illness caused by HIV. Antiretroviral therapy can cause dyslipidemia and liver disease.

Aim:

To evaluate liver enzymes and lipid profile in 200 HIV/AIDS patients and compare these in HIV /AIDS patients on ART and ART- naive.

Results:

The mean AST, ALT and ALP in the ART group were 58.93�89.19, 66.08�121.34 and 113.81�51.63 respectively as compared to 34.64� 24.69, 33.18 � 23.40 and 120.22 �125.41 respectively in the ART-naive group. The mean Cholesterol, TG, VLDL, LDL and HDL in the ART-group were 161.55 �77.33, 209.92 �93.29, 38.82 �13.93, 63.97 �28.54 and 48.52 �16.31 respectively compared to 138.65 � 41.87,178.02 �81.32 ,34.17 � 14.35, 58.50 � 33.02 and 46.53 � 16.25 respectively in the ART-naive group.

Conclusion:

Timely assessment of liver enzymes and lipid profile will help in better subsequent management of the HIV/AIDS patients.